[GA17-05] Effect sizes in benefit assessments
Last updated 23.02.2022
Project no.:
GA17-05
Report type:
Working paper
Status:
Commission completed
Department/Division:
Drug Assessment
Note:
The results of the work on the project were used in a publication on the results of the benefit assessment [1] and in the development of a methodology for assessing the extent of added benefit in the case of continuous outcomes [2].
- [1] Wieseler B, McGauran N, Kaiser T. New drugs: where did we go wrong and what can we do better? BMJ 2019; 366 :l4340 doi:10.1136/bmj.l4340
- [2] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (2022, 24.01.2022). "Allgemeine Methoden; Version 6.1." Retrieved 24.01.2022, from https://www.iqwig.de/methoden/allgemeine-methoden-v6-1.pdf.